These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20715915)

  • 21. Costing bias in economic evaluations.
    Frappier J; Tremblay G; Charny M; Cloutier LM
    J Med Econ; 2015; 18(8):596-9. PubMed ID: 25800456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers and potential solutions to providing optimal guideline-driven care to patients with diabetes in the U.S.
    Vigersky RA; Fitzner K; Levinson J;
    Diabetes Care; 2013 Nov; 36(11):3843-9. PubMed ID: 24159181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of diabetes care: prevent diabetes or face catastrophe.
    Bhansali A
    J Assoc Physicians India; 2013 Feb; 61(2):95. PubMed ID: 24471246
    [No Abstract]   [Full Text] [Related]  

  • 24. Methodological considerations in cost of prostate cancer studies: a systematic review.
    Molinier L; Bauvin E; Combescure C; Castelli C; Rebillard X; Soulié M; Daurès JP; Grosclaude P
    Value Health; 2008; 11(5):878-85. PubMed ID: 18494749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes in children.
    Edate S; Debono R; Paul SP
    Community Pract; 2015 Jul; 88(7):30-1, 34-5; quiz 35. PubMed ID: 26373021
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cost-effectiveness analysis for diabetes care].
    Fukuda H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():707-12. PubMed ID: 27266179
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of patient sample on costs of events in pharmacoeconomic models.
    Mullins CD; Subedi PR; Turk F
    Expert Rev Pharmacoecon Outcomes Res; 2008 Oct; 8(5):463-9. PubMed ID: 20528331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply to commentary on costs of diabetes and its complications in Poland.
    Leśniowska J
    Eur J Health Econ; 2015 Mar; 16(2):227. PubMed ID: 25487550
    [No Abstract]   [Full Text] [Related]  

  • 29. A mathematical model for the burden of diabetes and its complications.
    Boutayeb A; Twizell EH; Achouayb K; Chetouani A
    Biomed Eng Online; 2004 Jun; 3(1):20. PubMed ID: 15222886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico.
    Arredondo A; de Icaza E
    Diabetologia; 2009 Aug; 52(8):1693-5. PubMed ID: 19504083
    [No Abstract]   [Full Text] [Related]  

  • 31. Commentary to: Costs of diabetes and its complications in Poland.
    Fayaz-Bakhsh A; Sarvari Mehrabad R
    Eur J Health Econ; 2015 Mar; 16(2):225-6. PubMed ID: 25355296
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in diabetes information.
    Tuomilehto J
    Prim Care Diabetes; 2011 Jul; 5(2):71-2. PubMed ID: 21679888
    [No Abstract]   [Full Text] [Related]  

  • 33. The rising cost of diabetes care in the USA.
    Peter P; Lipska K
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):479-80. PubMed ID: 27156052
    [No Abstract]   [Full Text] [Related]  

  • 34. Costs of diabetes. A methodological analysis of the literature.
    Pagano E; Brunetti M; Tediosi F; Garattini L
    Pharmacoeconomics; 1999 Jun; 15(6):583-95. PubMed ID: 10538331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data.
    Corro Ramos I; van Voorn GAK; Vemer P; Feenstra TL; Al MJ
    Value Health; 2017 Sep; 20(8):1041-1047. PubMed ID: 28964435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights offered by economic analyses.
    Herman WH
    Diabetes Care; 2014 Sep; 37(9):2424-6. PubMed ID: 25147252
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peri-operative adjustment and treatment of diabetes mellitus].
    Zander JF; Risse A
    Orthopade; 2009 Sep; 38(9):818-27. PubMed ID: 19756493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-of-illness studies. Useful for health policy?
    Koopmanschap MA
    Pharmacoeconomics; 1998 Aug; 14(2):143-8. PubMed ID: 10186453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award Lecture, 2006.
    Herman WH
    Diabetes Care; 2007 Jul; 30(7):1912-9. PubMed ID: 17496237
    [No Abstract]   [Full Text] [Related]  

  • 40. The cost of diabetes: time for a different approach?
    Dixon S; Currie CJ; Peters JR
    Diabet Med; 2000 Dec; 17(12):820-2. PubMed ID: 11168322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.